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Previous studies have demonstrated that haptens induce
several phenotypic and functional changes of dendritic
cells in vivo as well as in vitro. Although recently, the
crucial role of p38 mitogen-activated protein kinase
has been reported in the activation of dendritic cells by
haptens, the signal transduction elements involved in
each phenotypic and functional changes that occur in
the activation of dendritic cells by haptens remain un-
known. Therefore, we examined the role of mitogen-
activated protein kinases and nuclear factor-jB in the
signal transduction of dendritic cells stimulated with
two representative haptens, i.e., NiCl2 and 2,4-dinitro-
chlorobenzene. Human monocyte-derived dendritic
cells stimulated with 2,4-dinitrochlorobenzene induced
the phosphorylation of p38 and stress-activated protein
kinase/c-jun N-terminal kinases, whereas NiCl2 induced
that of p44/42 extracellular signal-regulated kinases,
p38, and stress-activated protein kinase/c-jun N-term-
inal kinases. In addition, NiCl2 phosphorylated inhibi-
tor jB and activated nuclear factor-jB. In contrast,
primary irritants, e.g., benzalkonium chloride, or so-
dium lauryl sulfate, did not activate these signal trans-
duction pathways. By using speci¢c inhibitors for
extracellular signal-regulated kinases and p38 pathways,
PD98059 and SB203580, respectively, we demonstrated
that the augmentation of CD86, HLA-DR, and CD83,
and the production of interleukin-8 along with its in-
creased mRNA expression by monocyte-derived den-
dritic cells stimulated with 2,4-dinitrochlorobenzene,
and the augmentation of CD83 and the interleukin-12
p40 production by monocyte-derived dendritic cells sti-
mulated with NiCl2, were suppressed by SB203580,
whereas PD98059 suppressed the production of interleu-
kin-1b and tumor necrosis factor-a, together with their
increased mRNA expression by monocyte-derived den-
dritic cells treated with NiCl2. On the other hand, in
spite of the activation of nuclear factor-jB by mono-
cyte-derived dendritic cells stimulated with NiCl2, nu-
clear factor-jB inhibitor did not signi¢cantly a¡ect the
phenotypic and functional changes in the activation of
monocyte-derived dendritic cells. These data indicate
that NiCl2 and 2,4-dinitrochlorobenzene stimulate dif-
ferent signal transduction pathways in monocyte-de-
rived dendritic cells, and subsequently induce di¡erent
phenotypic and functional changes in them. Key words:
cellular activation/dendritic cells/haptens/Langerhans cells/
migration. J Invest Dermatol 120:390 ^399, 2003
I
t is well known that, although dendritic cells (DC) are the
most potent antigen-presenting cells (APC) for helper T
cells as well as cytotoxicTcells among various APC (Stein-
man, 1991), they reside in nonlymphoid organs and show
extremely active endocytosis as well as antigen-processing
but weak antigen-presenting functions (Romani et al, 1989a). In
response to stimuli derived from microorganisms, such as lipopo-
lysaccharide (LPS), these precursor DC migrate to T cell zones of
lymph nodes (Macatonia et al, 1987; Kripke et al, 1990) and mature
into e¡ective APC by ceasing endocytosis as well as the antigen-
processing function, but by stabilizing the expression of class II^
peptide complexes (Stossel et al, 1990; Kampgen et al, 1991) and
increasing the expression of CD80 or CD86 (Romani et al,
1989b; Symington et al, 1993; Girolomoni et al, 1994; Ozawa et al,
1996). The immune system also responds to simple chemicals.
Whereas so-called adjuvants are usually required to activate the
innate immune system, including DC in T cell-mediated immu-
nity to protein antigens, the allergic contact hypersensitivity reac-
tion to simple chemicals does not require the help of an adjuvant,
but can be induced by the simple application of these chemicals
to the skin.When we consider the similarities between immunity
to simple chemicals and that to infectious agents, it is reasonable
to speculate that hapten itself stimulates DC maturation.
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Indeed, we reported that murine Langerhans cells upregulate
their expression of class II major histocompatibility complex anti-
gen and antigen-presenting function after hapten painting to the
skin, whereas chemicals that simply irritate the skin rather than
sensitize animals cannot induce this phenomenon (Aiba and
Katz, 1990). Afterwards, we demonstrated that the application of
haptens to murine skin was accompanied by the upregulation of
several costimulatory molecules on Langerhans cells, i.e., CD40,
CD54, CD80, and CD86 (Ozawa et al, 1996). In addition, Enk
and Katz (1992) demonstrated a crucial role played by interleukin
(IL)-1b secreted by Langerhans cells themselves in their increased
expression of class II major histocompatibility complex antigen
after exposure to hapten application.
In addition to these in vivo studies, using human monocyte-de-
rived DC (MoDC), Aiba et al (1997) demonstrated in vitro that
puri¢ed MoDC responded to haptens such as NiCl2 and 2,4-di-
nitrochlorobenzene (DNCB), but not to irritants such as ben-
zalkonium chloride (BC) or sodium lauryl sulfate (SLS), by
signi¢cantly augmenting their expression of CD54, CD86, and
HLA-DR and by increasing their production of proin£amma-
tory cytokines. Furthermore, using Langerhans cell-like DC in-
duced from peripheral blood monocytes in the presence of
transforming growth factor-b1, granulocyte-macrophage col-
ony-stimulating factor (GM-CSF), and IL-4 (monocyte-derived
Langerhans cells) according to a procedure reported by Geiss-
mann et al (1998), it has been shown that in vitro treatment with
haptens can induce the phenotypic and functional changes in
monocyte-derived Langerhans cells seen in epidermal Langer-
hans cells during the initiation phase of contact hypersensitivity
reaction in vivo (Aiba et al, 2000), e.g., the downregulation of E-
cadherin (Schwarzenberger and Udey, 1996) and cutaneous lym-
phocyte antigen (Ebner et al, 1998), the induction of matrix
metalloproteinase-9 expression (Kobayashi, 1997), and the aug-
mentation of some of b1-integrins (Staquet et al, 1992; Aiba et al,
1993), CD44 and some of its variants (Weiss et al, 1997), as well as
the expression of CCR7 mRNA that enable Langerhans cells to
respond to MIP-3b (Dieu et al, 1998; Sallusto et al, 1998; Saeki et al,
1999).
In spite of these observations, however, it is still unknown how
di¡erent haptens can stimulate MoDC to acquire a mature phe-
notype. So far, there have been few reports on the signal trans-
duction elements stimulated by haptens. Kuhn et al (1998)
demonstrated that strong sensitizers could induce the formation
of phosphotyrosine in MoDC in vitro, suggesting that tyrosine
phosphorylation plays an important part in the activation of
MoDC by haptens. Recently, Ardeshna et al (2000) have reported
the precise mechanisms for the survival and maturation of
MoDC stimulated by LPS. According to their report, both p38
mitogen-activated protein kinase (MAPK) and nuclear factor
(NF)-kB signal transduction pathways are responsible for the up-
regulation of CD80, CD83, and CD86 induced by LPS, whereas
phosphoinositol 3-kinase is important in maintaining their sur-
vival. Therefore, it is conceivable that haptens also stimulate p38
MAPK, NF-kB, or phosphoinositol 3-kinase. In fact, using
MoDC, Arrighi et al (2001) have reported that 2,4-dinitro£uoro-
benzene and NiSO4 induce p38 MAPK phosphorylation, and
that the augmentation of CD80 and CD83 induced by NiSO4 is
partially suppressed by p38 MAPK inhibitor. The MAPK are an
important group of serine/threonine signaling kinases that, by
modulating the phosphorylation and hence activation status of
transcription factors, link transmembrane signaling with gene in-
duction events in the nucleus. There are at least three genetically
distinct MAPK pathways in mammals, including the extracellu-
lar signal-regulated kinases (ERK), the c-jun N-terminal kinases
(JNK), and the p38 MAPK. These kinases are activated by phos-
phorylation on both threonine and tyrosine residues in a regula-
tory TXY loop present in all MAPK. This phosphorylation is
performed by distinct upstream dual-speci¢city MAPK kinases
(MAPKK). Activated MAPK then phosphorylate their respective
substrate on serine or threonine residues (Whitmarsh and Davis,
1996; Minden and Karin, 1997; Ip and Davis, 1998).
Therefore, in this study, to elucidate further the mechanism for
the induction of DC maturation by haptens, we examined the
activation of three distinct MAPK pathways such as ERK, JNK,
and p38 MAPK and NF-kB on human MoDC by two represen-
tative haptens with di¡erent chemical structures, i.e., DNCB
and NiCl2. By using PD98059 and SB203580, which are rela-
tively speci¢c inhibitors for ERK and p38 MAPK pathways,
respectively, and pyrrolidine dithiocarbamate (PDTC), a NF-kB
inhibitor, we investigated which kinds of signal transduction
pathways mediate the augmentation of CD80, CD83, or CD86
expression and the increased production of IL-1b, IL-8, IL-
12p40, or tumor necrosis factor (TNF)-a by MoDC stimulated
with these haptens. In these studies, we found that DNCB and
NiCl2 stimulated MoDC via di¡erent signal transduction path-
ways. Namely, DNCB preferentially stimulated p38 MAPK,
whereas NiCl2 activated ERK and NF-kB in addition to p38
MAPK.
MATERIALS ANDMETHODS
Media and reagents The medium used in the study was RPMI-1640,
including 25 mM Hepes bu¡er (Sigma, St Louis, MO) supplemented
with 2 mM L-glutamine, 1 mM sodium pyruvate, 1% penicillin,
streptomycin, and fungizone antibiotic solution (Sigma) and 10% fetal
bovine serum (Bioserum, Canterbury, Victoria, Australia) (complete
medium). The bu¡er used for the puri¢cation of CD14þ monocytes from
peripheral blood mononuclear cells was phosphate-bu¡ered saline (PBS)
supplemented with 1% bovine serum albumin (less than 1 ng per mg of
detectable endotoxin) (Sigma) and 5 mM ethylenediamine tetraacetic acid
[Magnetic activated cell sorter (MACS) bu¡er]. NiCl2 (Sigma), and
DNCB (Wako Pure Chemicals, Osaka, Japan) were used for the
stimulation of MoDC. The endotoxin content of the ¢nal dilution used
waso30 pg per ml, as determined by the Limulus amebocyte lysate assay
(Seikagaku Co. Inc., Tokyo, Japan). We used the following monoclonal
antibodies for immunostaining: £uorescein isothiocyanate (FITC)-
conjugated-anti-CD40, FITC-conjugated-anti-CD86 antibodies, FITC or
phycoerythrin (PE)-conjugated isotype-matched mouse control antibodies
(IgG2a and IgG2b) (PharMingen, San Diego, CA), PE-conjugated anti-
CD80, PE-conjugated anti-HLA-DR antibodies (Becton-Dickinson, San
Jose, CA), PE-conjugated anti-CD83 antibody (Immunotech, Marseilles,
France), FITC-conjugated anti-CD54 antibody (Ancell, Bayport, MN),
and PE-conjugated anti-CD1a antibody (Coulter, Hialeah, FL). MACS
colloidal supermagnetic microbeads conjugated with anti-human CD14
monoclonal antibody (CD14 microbeads) were purchased from Miltenyi
Biotec Inc. (Sunnyvale, CA). Recombinant human (rh) GM-CSF was a
gift from Kirin Brewery Co. (Tokyo, Japan), and rhIL-4 was purchased
from Peprotech EC Ltd (London, U.K.). NiCl2, BC, or SLS (Sigma) was
solubilized in distilled water, whereas DNCB was solubilized in dimethyl
sulfoxide (DMSO) at a concentration of 1 M. MEK 1 inhibitor PD98059
and p38 MAPK inhibitor SB203580 were purchased from New England
BioLabs Inc. (Beverly, MA) and Calbiochem (La Jolla, CA), respectively.
Each inhibitor was reconstituted in DMSO at a stock concentration of
20 mM and 5 mM, respectively. The ¢nal concentration of DMSO was
always less than 0.1% and cultures of MoDC with 0.1% DMSO were
also examined as a control. A NF-kB inhibitor, PDTC, was purchased
from Calbiochem and solubilized in distilled water.
Culture of MoDC from peripheral blood monocytes and chemical
treatment with haptens in the presence or absence of MAPK
inhibitor Peripheral blood mononuclear cells were isolated from
heparinized fresh leukocyte-enriched bu¡y coats from di¡erent donors
using Lymphoprep (Nycomed Pharma As, Oslo, Norway). After several
washes with PBS, 1108 peripheral blood mononuclear cells were treated
with 150 ml of CD14 microbeads in 600 ml of MACS bu¡er at 41C for
30 min. After washing with MACS bu¡er, the cells coated with CD14
microbeads were separated by a magnetic cell separator, MACS (Miltenyi
Biotech), according to the manufacturer’s protocol. Before culturing, we
examined the percentage of CD14þ cells in these preparations by £ow
cytometry and used cell specimens containing more than 98% of CD14þ
cells in the experiments.
CD14þ monocytes (2106 per ml) were cultured in complete medium
containing 50 ng per ml of rhGM-CSF and 100 ng per ml rhIL-4 for 5 d.
One half of the culture medium was changed on day 3 and day 5. On the
¢fth day, the cells were treated with di¡erent concentrations of NiCl2,
DNCB, SLS, or BC. To analyze ERK, JNK, p38 MAPK, and IkB
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phosphorylation, these cells were cultured for 30 min or 1 h. To examine
the e¡ects of MAPK inhibitors or NF-kB inhibitor, MoDC were exposed
to various concentrations of PD98059, SB203580, or PDTC, 1 h prior to the
stimulation by chemicals, and were then cultured for 48 h before collection
of the supernatants or £ow cytometrical analysis.
Flow cytometry Forty-eight hours after treatment with the chemicals,
the surface expression of CD40, CD54, CD80, CD83, CD86, or HLA-DR
antigen was analyzed by £ow cytometry. Cell staining was performed
using a combination of FITC-conjugated anti-CD86 (10 mg per ml),
FITC-conjugated anti-CD40 (10 mg per ml), FITC-conjugated anti-CD54
(10 mg per ml), or FITC-conjugated isotype control (10 mg per ml)
antibody, and PE-conjugated anti-HLA-DR antigen (10 mg per ml), PE-
conjugated anti-CD83 (10 mg per ml), PE-conjugated anti-CD80 (10 mg
per ml), or PE-conjugated isotype control (10 mg per ml) antibody. After
washing with PBS supplemented with 1% bovine serum albumin and
0.02% NaN3 (£uorescence-activated cell sorter bu¡er), the cells were
analyzed by FACScan using CellQuest software (Becton Dickinson).
Dead cells were gated out after staining with 0.5 mg propidium iodide
solution per ml.
Enzyme-linked immunosorbent assay for cytokine production The
culture supernatants of MoDC treated with haptens in the presence or
absence of MAKP inhibitors or PDTC were recovered 48 h after culture.
Their production of IL-1b, TNF-a, IL-8, and IL-12p40 was measured by
enzyme-linked immunosorbent assay kits obtained from Endogen, Inc.
(Woburn, MA) for TNF-a and IL-8 and from R&D Systems
(Minneapolis, MN) for IL-1b, IL-12p40, using 96-well microtiter plates,
according to each manufacturer’s instructions. The levels of TNF-a, IL-8,
and IL-12p40 were calculated by using a standard curve obtained with
rhIL-1b (from 3.9 to 250 pg per ml), rhTNF-a (from 0 to 400 pg per ml),
rhIL-8 (from 0 to 1000 pg per ml), and rhIL-12p40 (from 0 to 2000 pg per
ml). When the culture supernatants contained cytokines over the upper
limits of the standard curves, they were measured again after optimal
dilution.
Immunoblotting MoDC were either unstimulated or stimulated with
10 mg per ml, 30 mg per ml of SLS, 10 mg per ml, 30 mg per ml of BC,
10 mM, 30 mM, and 100 mM of DNCB, 100^300 mM, and 1000 mM of
NiCl2 for 1 h. Immunoblotting of phosphorylated p42/44 ERK, SAPK/
JNK, p38 MAPK, or IkB was performed using p42/44 ERK, SAPK/JNK,
p38 MAPK, or IkB immunoblotting kits purchased from New England
Biolabs. The cells were washed twice in cold PBS and resuspended
in 100 ml of lysis bu¡er (1% Nonidet P-40, 20 mM Tris^HCl (pH 8.0),
137 mM NaCl, 10% glycerol, 2 mM ethylenediamine tetraacetic acid, 10 mg
per ml leupeptin, 10 mg per ml aprotinin, 1 mM phenylmethylsulfonyl
£uoride, and 1 mM sodium orthovandate). The nuclei and the insoluble
cell debris were removed by centrifugation at 41C for 10 min at 14,000 g.
The postnuclear extracts were collected and used as total cell lysates. Total
cell lysates were suspended in 2 sodium dodecyl sulfate sample
bu¡er (313 mM Tris^HCl, pH 6.8, 10% sodium dodecyl sulfate,
2-mercaptoethanol, 50% glycerol, and 0.01% bromophenol blue) and
heated at 951C for 3 min. The protein samples were fractionated by 12%
sodium dodecyl sulfate^polyacrylamide gel electrophoresis and transferred
on to polyvinylidene di£uoride membranes (Millipore, Bedford, MA).The
nonspeci¢c antibody binding sites on the membranes were blocked with
1% bovine serum albumin, 0.01% Tween 20 in saline (10 mM Tris^HCl
(pH 7.4) 100 mM NaCl) for 20 min at 371C. Immunoblotting of ERK,
SAPK/JNK, p38 MAPK, and IkB was performed according to the
instruction manual. Brie£y, the membranes were incubated for 16 h at
41C with rabbit polyclonal antibodies to anti-tyrosine phosphorylated
p42/44 ERK, SAPK/JNK, p38 MAPK, or anti-serine (Ser32/36)
phosphorylated IkB, washed for 15 min, and incubated with horseradish
peroxidase (HRP)-conjugated secondary antibodies for 1 h at room
temperature. Blots were visualized by enhanced chemiluminescence. To
ensure that there were similar amounts of MAPK in each sample, the
same membranes were stripped o¡, reprobed with monoclonal antibodies
to p42/44 ERK, SAPK/JNK, or p38 MAPK, and developed with HRP-
conjugated secondary antibodies by enhanced chemiluminescence. For
IkB, we prepared two immunoblotted membranes, which were treated
using the same amount of total cell lysate of each sample, and
immunostained with anti-non-phosphorylated IkB antibody and anti-
phosphorylated IkB antibody, respectively.
Microwell colorimetric NF-jB assay The NF-kB p65 activity of
MoDC either unstimulated or stimulated with 30 mM of DNCB, 300 mM
of NiCl2, or 10 ng per ml of LPS was examined using a NF-kB p65
transcriptional factor assay kit (Active Motif North America, Carlsbad,
CA). Thirty minutes and 1 h after stimulation, cells were rinsed twice
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with cold PBS and centrifuged for 10 min at 1400 r.p.m. (360 g). The pellet
was then resuspended in 100 ml of Lysis Bu¡er containing a protease
inhibitor cocktail and 5 mM dithiothreitol. After 10 min on ice, the lysate
was centrifuged for 20 mM at 14,000 r.p.m. (10,976 g). The supernatant
constitutes the total protein extract and can be kept frozen at 701C. The
activity of NF-kB in each sample was measured by a microwell
colorimetric NF-kB assay using a NF-kB p65 transcriptional factor assay
kit. To con¢rm the speci¢city of binding, the wild-type or mutated
consensus oligonucleotide was added to the corresponding wells.
Quantitative real-time reverse transcription^PCR Quantitative,
£uorescent PCRwas performed using the TaqMan system (ABI 7700; PE
Applied Biosystems, Foster City, CA). Sequences for human GAPDH,
CD86, and cytokines were obtained from GenBank. We chose forward
primers and reverse primers to span exon^intron boundaries. TaqMan
probes were chosen to be used with these primers with Primer Express
version. 1.0 (PE Applied Biosystems). Forward and reverse primers were
made by Operon (Nihon Gene Research Laboratories Inc., Sendai, Japan),
whereas TaqMan probes were made by PE Applied Biosystems. The
primers and probes used in these studies are shown in Table I. RNAwas
extracted by using the guanidinium thiocyanate method described by the
manufacturer (ISOGEN; Nippon gene Inc., Toyama, Japan) from MoDC
either unstimulated or stimulated with 30 mM of DNCB or 300 mM of
NiCl2 for 2 h and 6 h in the presence or absence of MAPK inhibitors or
PDTC. First strand cDNA was synthesized from total RNA extracted in
RNAse-free conditions. cDNA was obtained from total RNA using
TaKaRa RNA PCR kit (AMV) (Takara Biochemicals, Osaka, Japan), as
described by the manufacturer’s protocol. PCR for GAPDH, CD86, and
cytokines were performed in duplicate in 30 ml total reaction volumes
with 66 nM TaqMan probe, 400 nM forward primers, 400 nM reverse
primers, and 2TaqMan universal PCR Master (PE Applied
Biosystems). Thermal cycling was performed with 2 min at 501C for
depleting contaminated RNA, 10 min denaturation at 951C, followed by
40 cycles at 951C for 15 s, 601C for 1 min in the ABI Prism 7700
detection system (PE Applied Biosystems). Levels of cDNA for GAPDH,
CD86, or each cytokine generated from cellular RNAwere calculated by
using standard curves generated with bona ¢de human cDNA for GAPDH,
CD86, or each cytokine where there was a linear relationship between the
number of cycles required to exceed the threshold and the number of
copies of cDNA added (Anonymous, 1997).
RESULTS
DNCB and NiCl2 activated p38 MAPK and ERK
di¡erently To study the signal transduction elements for
haptens, we examined the phosphorylation of three MAPK in
MoDC 1 h after hapten, LPS, or irritant stimulation (Fig 1).
MoDC stimulated with DNCB induced strong phosphorylation
of p38 MAPK and SAPK/JNK in a concentration-dependent
manner, 1 h after treatment. DNCB also phosphorylated p44/42
ERK at some restricted concentrations; however, p44/42 ERK
were also phosphorylated in MoDC treated with 0.1% DMSO
that served as a solvent control for DNCB. Therefore, it is
impossible to evaluate the e¡ect of DNCB on the activation of
p44/42 ERK. On the other hand, NiCl2 induced strong
phosphorylation of p44/42 ERK in a concentration-dependent
manner, and that of p38 MAPK and SAPK/JNK. As we
solubilized NiCl2 in distilled water, we could evaluate
phosphorylation of p44/42 ERK in MoDC treated with NiCl2
by comparing that in nontreated DC. We stimulated MoDC
with LPS as a positive control. LPS phosphorylated all three
MAPK. In contrast, BC used as a representative for primary
irritants did not augment any MAPK at its nontoxic
concentrations, 30 mg per ml or less. SLS, another irritant used
at less than 100 mg per ml, also did not induce the
phosphorylation of any MAPK (data not shown).
NiCl2, but not DNCB phosphorylated IjB and activated
NF-jB Next, we investigated whether these two haptens,
LPS, or irritants activated the NF-kB pathway. When we
examined the phosphorylation of IkB, only NiCl2 and LPS used
as a positive control, but not DNCB, phosphorylated IkB 1 h
Figure1. Haptens induce phosphorylation
of MAPK in MoDC. MoDC were either un-
stimulated or stimulated with di¡erent concen-
trations of BC, NiCl2, DNCB, or 10 ng per ml
of LPS for 1 h. MoDC were also cultured with
0.1% of DMSO as a solvent control. Immuno-
blotting of phosphorylated ERK1/2, SAPK/
JNK, or p38 MAPK was performed using
ERK1/2, SAPK/JNK, and p38 MAPK immu-
noblotting kits. Blots were developed with
HRP-conjugated secondary antibodies and vi-
sualized by enhanced chemiluminescence. To
ensure similar amounts of MAPK for each sam-
ple, the same membrane was stripped o¡ and re-
probed with monoclonal antibodies to ERK1/2,
SAPK/JNK, or p38 MAPK. Similar results were
obtained in three di¡erent experiments (a). The
optical densities of the bands were determined
by scanning radiograms (b).
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after stimulation (Fig 2). Neither BC or SLS phosphorylated IkB
(data not shown). Consistent with the phosphorylation
of IkB, both NiCl2 and LPS induced the binding activity to
NF-kB p65 consensus sequence in the total protein extracts of
MoDC 30 min and 1 h after treatment. The speci¢city of the
binding was con¢rmed by the competitive inhibition with the
wild-type but not by mutated consensus oligonucleotides (Fig 3).
SB203580, but not PD98059, suppressed some of the
phenotypic changes of activated MoDC induced by
haptens Because DNCB and NiCl2 distinctly activated
MAPK in MoDC, we studied the e¡ects of MAPK inhibitors
on the phenotypic changes of MoDC induced by these haptens.
We examined the following surface markers that are related to
the function and maturation of DC, i.e., CD40, CD54, CD80,
CD83, CD86, and HLA-DR. Consistent with our previous
observation (Aiba et al, 1997), DNCB augmented the expression
of CD86 and HLA-DR antigen, and, although weakly, that of
CD83, whereas NiCl2 augmented that of CD86, HLA-DR
antigen, and CD83 (Fig 4). When we added MAPK inhibitors
in this system, we found that SB203580 suppressed the
augmented expression of CD86, HLA-DR antigen, and CD83
induced by DNCB, and that of HLA-DR antigen and CD83
induced by NiCl2 in a concentration-dependent manner. Figure
4 is a representative £ow cytometry of MoDC stimulated with
the haptens in the presence or absence of di¡erent concentrations
of SB203580. Figure 5 shows summarized data from four
Figure 2. NiCl2, but not DNCB phosphorylates IjB in MoDC.
MoDC were either unstimulated or stimulated with di¡erent concentra-
tions of NiCl2, DNCB, or 10 ng per ml of LPS for 1 h. Immunoblotting
of phosphorylated IkB was performed using IkB immunoblotting kits. In
this experiment, we prepared two immunoblotted membranes, whichwere
treated using the same amount of total cell lysate of each sample, and im-
munostained with anti-nonphosphorylated IkB antibody and anti-phos-
phorylated IkB antibody, respectively. Blots were developed with HRP-
conjugated secondary antibodies and visualized by enhanced chemilumi-
nescence. Similar results were obtained in three di¡erent experiments.
Figure 3. NiCl2, but not DNCB activates NF-jB. MoDC were either
unstimulated or stimulated with 30 mM of DNCB, 300 mM of NiCl2, or 10
ng per ml of LPS. The total cell extracts were prepared from MoDC 30
min and 1 h after stimulation. The activity of NF-kB in each sample was
measured by microwell colorimetric NF-kB assay using a NF-kB p65 tran-
scriptional factor assay kit. To con¢rm the speci¢city of binding, the wild-
type or mutated consensus oligonucleotide was added to the corresponding
wells. Similar results were obtained in two di¡erent experiments.
Figure 4. SB203580 suppresses the augmentation of CD86 and HLA-
DR antigen expression on MoDC treated with DNCB. MoDC were
pretreated with various concentrations of SB203580 for 1 h and then cul-
tured with 300 mM of NiCl2, 30 mM of DNCB, or 10 ng per ml of LPS.
After 2 d of culture, their surface expression of costimulatory molecules
and HLA-DR antigen was analyzed by £ow cytometry. The histogram of
hapten-treated MoDC expressing each costimulatory molecule or HLA-
DR antigen in the absence or the presence of various concentrations of
SB203580 is expressed as a dotted line (0.1 mM), a solid-dotted line (1
mM), and a thick solid line (10 mM) or a solid line (0 mM). A shaded line
indicates the histogram of nontreated DC. This is a representative £ow cy-
tometry of four independent experiments.
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di¡erent subjects that demonstrate the changes of mean
£uorescence intensity of CD86, CD83, and HLA-DR on
hapten-treated MoDC plotted against di¡erent concentrations of
SB203580. The augmentation of CD86 on MoDC induced by
NiCl2 was insensitive to the treatment of SB203580. The
treatment with SB203580 did not induce any signi¢cant changes
on the DC phenotypes in the absence of the haptens.
In contrast to the treatment with SB203580, that with
PD98059 did not show any suppressive e¡ects on the phenotypic
changes induced by the haptens on MoDC, but rather augmented
the expression of several phenotypic markers, such as CD86,
CD83, and HLA-DR antigen. Figure 6 is a representative £ow
cytometry of MoDC stimulated with the haptens in the
presence or absence of di¡erent concentrations of PD98059. The
stimulatory e¡ects of PD98059 on the expression of CD86,
CD83, and HLA-DR antigen by MoDC was remarkable with a
suboptimum stimulation of the haptens, such as 300 mM of NiCl2,
or 10 mM of DNCB. Figure 7 shows summarized data of the
mean £uorescence intensity of CD86 on MoDC obtained from
two di¡erent subjects, which were unstimulated or stimulated
with the suboptimum concentrations of the haptens in the
presence of di¡erent concentrations of PD98059. Unexpectedly,
PD98059 alone induced augmented expression of CD86 in a
concentration-dependent manner. Furthermore, it increased the
expression of CD86 synergistically with the haptens. Similarly,
PD98059 also augmented CD83 and HLA-DR antigen on
MoDC by itself (data not shown).
In contrast to the signi¢cant changes observed with £ow
cytometry in CD86 expression between the nontreated MoDC
and MoDC treated with the haptens or between the MoDC
treated with DNCB in the presence and absence of the MAPK
inhibitors, we could not ¢nd any signi¢cant changes in the
expression of CD86 mRNA among them (Fig 9).
SB203580 and PD98059 di¡erently regulate the cytokine
production and the expression of cytokine mRNA by
MoDC stimulated with the haptens Next we examined the
e¡ects of these MAPK inhibitors on the cytokine production
and the expression of cytokine mRNA by MoDC stimulated
with the haptens. Figures 8 and 9 demonstrate the production
of cytokines and their mRNA expression, respectively.When we
added the haptens to the culture of MoDC, DNCB induced
signi¢cant production of only IL-8, whereas NiCl2 induced that
of IL-1b, IL-8, IL-12p40, and TNF-a. None of these haptens
Figure 6. PD98059 does not suppress the
augmented expression of costimulatory
molecules or HLA-DR antigen on
MoDC treated with haptens. MoDC
were pretreated with various concentrations
of PD98059 for 1 h and then cultured with
300 mM or 1 mM of NiCl2 or 10 mM or 30
mM of DNCB. After 2 d of culture, their
surface expression of CD86, CD83, and
HLA-DR antigen was analyzed by £ow cy-
tometry. The histogram of hapten-treated
MoDC expressing CD83, CD86, or HLA-
DR antigen in the absence or the presence
of various concentrations of PD98059 is ex-
pressed as a dotted line (10 mM), a solid-
dotted line (30 mM), and a thick solid line
(100 mM) or a solid line (0 mM). A shaded
line indicates the histogram of nontreated
DC. This is a representative £ow cytometry
of two independent experiments.
Figure 5. The summarized data of the e¡ects of SB203580 on the augmented expression of CD86 and HLA-DR antigen by MoDC treated
with haptens. MoDC were pretreated with various concentrations of SB203580 for 1 h and then cultured with 300 mM of NiCl2 or 30 mM of DNCB.
After 2 d of culture, their surface expression of CD83, CD86, and HLA-DR antigen was analyzed by £ow cytometry. Changes in the mean £uorescence
intensity were plotted against the concentrations of SB203580. Di¡erent symbols correspond to di¡erent experiments.
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induced the production of IL-12p70 by MoDC (data not shown).
In these cultures, SB203580 suppressed IL-8 production by
MoDC stimulated with DNCB, and the IL-12p40 production
by MoDC stimulated with NiCl2 in a concentration-dependent
manner. On the other hand, PD98059 suppressed the IL-1b, IL-
8, and TNF-a production by MoDC stimulated with NiCl2.
Again, the treatment of MoDC with PD98059 enhanced the
production of IL-12p40 synergistically with NiCl2, although the
treatment with PD98059 alone did not increase it (Fig 8).
Consistent with the production of cytokines, the expression of
IL-1b, IL-8, and TNF-a mRNA by MoDC was augmented
by the treatment with both haptens, although NiCl2 induced
these mRNA more strongly than did DNCB. Furthermore,
SB203580 signi¢cantly suppressed the augmented expression of
IL-1b and IL-8 mRNA by MoDC treated with DNCB,
whereas PD98059 suppressed that of IL-1b, IL-8, and TNF-a by
MoDC treated with NiCl2. Neither hapten augmented the
expression of IL-12p40 mRNA. Again, the treatment of MoDC
with PD98059 enhanced the expression of IL-12p40 of MoDC
treated with either DNCB or NiCl2. In these samples, there was
no signi¢cant change in GAPDH mRNA expression among
MoDC with various treatments (Fig 9).
NiCl2 does not induce the augmentation of CD86 expression
and the cytokine production by MoDC through the NF-jB
pathway As NiCl2 induced the activation of NF-kB, we next
examined the e¡ects of NF-kB inhibitor, PDTC, on the
augmentation of CD86 and the cytokine production. Figure 10
shows representative data from three di¡erent experiments. One
hundred and ¢fty micromoles per liter of PDTC marginally
suppressed the augmentation of CD86 expression by MoDC
stimulated with NiCl2, whereas it did not in£uence that of
CD83. For cytokine production, PDTC did not suppress the
production of IL-1b, IL-8,TNF-a, or IL-12p40 (data not shown).
Figure 7. The summarized data of the e¡ects of PD98059 on the
augmented expression of CD86 and HLA-DR antigen by MoDC
treated with haptens. MoDC were pretreated with various concentra-
tions of PD98059 for 1 h and then cultured with 300 mM of NiCl2 or
10 mM of DNCB. After 2 d of culture, their surface expression of CD86
was analyzed by £ow cytometry. Changes in the mean £uorescence inten-
sity were plotted against the concentrations of PD98059.
Figure 8. SB203580 and PD98059 di¡erently suppress the cytokine
production by MoDC stimulated with haptens.To examine the e¡ects
of MAPK inhibitors on the production of cytokines by MoDC stimulated
with the haptens, MoDC were pretreated with various concentrations of
SB203580 or PD98059 for 1 h and then cultured with 300 mM NiCl2 or
30 mM of DNCB for 48 h. After culture, the supernatants were recovered
and examined for the production of IL-1b, IL-8,TNF-a and IL-12p40 by
an enzyme-linked immunosorbent assay. Di¡erent symbols correspond to
di¡erent experiments. The data shown are the mean of triplicate determi-
nations with SEMo10% (data not shown).
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DISCUSSION
Although the signal transduction pathways that mediate each
phenotypic and functional change that accompanies DC matura-
tion are not fully clari¢ed, several recent papers have addressed
this issue. Ardeshna et al (2000) demonstrated the role of p38
MAPK and NF-kB pathways in the phenotypic changes of DC
that occur under the stimulation of LPS. They found that p38
MAPK was responsible for the augmentation of CD80, CD83,
and CD86, whereas the NF-kB pathway mediated that of
CD40, CD80, CD83, CD86, and HLA-DR. The role of p38
MAPK in the augmentation of CD80, CD83, and CD86 was
con¢rmed by Arrighi et al (2001), although they also detected its
role in the augmentation of CD1a, CD40, and HLA-DR. In con-
trast to the phenotypic changes induced by LPS, our understand-
ing of the role of MAPK or NF-kB in cytokine production by
DC is only fragmentary. Rescigno et al (1998) demonstrated by
using a murine GM-CSF-dependent DC line that TNF-a pro-
duction by DC that were stimulated by LPS was suppressed by
PD98059. Lu et al (1999) showed that the mice lacking MKK-3,
which activates p38 MAPK, were defective in IL-12p40 produc-
tion. These ¢ndings can be summarized as follows: (i) both p38
MAPK and NF-kB mediate at least the augmentation of CD80,
CD83, and CD86, and (ii) TNF-a and IL-12p40 production is
induced by ERK and p38 MAPK, respectively.
Most of these studies, however, analyzed DC stimulated by
LPS or TNF-a. It is well known that LPS or TNF-a introduces
Figure 9. SB203580 and PD98059 di¡erently suppress cytokine mRNA expression by MoDC stimulated with haptens. MoDC were
pretreated with 10 mM of SB203580 or with 50 mM of PD98059 or SB203580 for 1 h and then cultured with 30 mM of DNCB or 300 mM
of NiCl2 for 2 h or 6 h. Total RNAwas extracted from these MoDC and then cDNAwas reverse-transcribed from total RNA. Quantitative, £uorescent
PCR was performed using the TaqMan system. Levels of cDNA (copy number) for GAPDH, CD86 or each cytokine generated from cellular RNA
(50 ng) were calculated by using standard curves generated with bona ¢de human cDNA for GAPDH, CD86, or each cytokine where there is a linear
relationship between the number of cycles required to exceed threshold and the number of copies of cDNA added. This ¢gure shows representative data
from three di¡erent experiments.
Figure10. PDTC does not signi¢cantly suppress the augmentation
of CD86 or CD83 expression on MoDC treated with NiCl2. MoDC
were pretreated with 150 mM of PDTC for 1 h and then cultured without
or with 300 mM of NiCl2. After 2 d of culture, their surface expression of
CD86 and CD83 was analyzed by £ow cytometry. The histogram of non-
treated or NiCl2-treated MoDC expressing CD86 or CD83 in the absence
or the presence of 150 mM of PDTC is expressed as a solid line, or a thick
solid line, respectively, whereas that of DC without NiCl2 or PDTC treat-
ment is expressed as a shaded line. A dotted line indicates DC stained with
isotype control antibody.This shows representative data from four di¡erent
experiments.
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the signals into the cells via their speci¢c receptors, i.e., CD14 and
Toll-like receptor 4 for LPS (Guha and Mackman, 2001) and
TNF-R1 and TNF-R2 for TNF-a (Wajant and Scheurich, 2001).
In contrast, we do not have any information about how haptens
stimulate DC or whether haptens have their own speci¢c recep-
tors. Therefore, we cannot speculate on the signal transduction
pathways that mediate DC maturation after hapten stimulation
simply by analogy with those after LPS stimulation. So far, stu-
dies on the signal transduction pathways that mediate DC ma-
turation after hapten stimulation are very limited. Recently,
Arrighi et al (2001) have reported that 2,4 -dinitro£uorobenzene
and NiSO4 induced p38 MAPK phosphorylation, whereas
NiSO4 also slightly increased the phosphorylation of ERK, and
that the augmentation of CD80 and CD83 induced by NiSO4
and, to a lesser extent, that of CD86, was blocked by SB203580.
This study con¢rmed the p38 MAPK phosphorylation in
MoDC stimulated with haptens, such as DNCB and NiCl2, and
the suppressive e¡ect of SB203580 on the augmentation of CD83
by NiCl2. In addition, our data on the e¡ects of irritants on
MAPKor NF-kB were consistent with those reported by Arrighi
et al (2001). Furthermore, we found that SB203580 suppressed the
augmentation of CD86, CD83, and HLA-DR, and the produc-
tion of IL-8 as well as their increased mRNA expression by
MoDC stimulated with DNCB, and the IL-12p40 production
by MoDC stimulated with NiCl2, whereas PD98059 suppressed
the production of IL-1b, IL-8, and TNF-a, and their increased
mRNA expression by MoDC treated with NiCl2. Consistent
with the signi¢cant suppressive e¡ects of PD98059, we detected
strong phosphorylation of ERK by NiCl2, which is discrepant
with the data reported by Arrighi et al (2001). In our study, we
also detected the phosphorylation of ERK by DNCB at a re-
stricted concentration. As the DMSO that we used to solubilize
DNCB also phosphorylated ERK, however, we considered that
the phosphorylation of ERK by DNCB was not due to its bio-
logic e¡ect. Indeed, we could not detect any inhibitory e¡ects of
PD98059 on the cytokine production or augmentation of costi-
mulatory molecules stimulated by DNCB. In addition, we found
that only NiCl2, but not DNCB, activated NF-kB, although we
could not demonstrate any signi¢cant inhibitory e¡ects of PDTC
on the augmentation of CD86 or CD83, or the production of IL-
1b, IL-8,TNF-a, or IL-12p40 induced by NiCl2.
When we compared these data with those obtained from the
analysis of the signal transduction pathways in DC maturation
after LPS stimulation (Rescigno et al, 1998; Lu et al, 1999; Ardesh-
na et al, 2000; Arrighi et al, 2001), it becomes clear that haptens
share the similar pathways to induce phenotypic and functional
changes as those so far reported in DC stimulated by LPS, e.g.,
p38 MAPK for the augmentation of CD83, CD86, and HLA-
DR, the production of IL-8 and IL-12p40, and ERK for the pro-
duction of IL-1b and TNF-a. In our study, we could not
succeed in demonstrating the role of the activation of NF-kB in
the augmentation of CD83 or CD86, or the production of IL-1b,
IL-8, IL-12p40, or TNF-a by MoDC treated with NiCl2. So
far we have not found any reasonable explanation for this
observation.
Interestingly, in contrast to LPS and TNF-a that activate both
MAPK and NF-kB, DNCB stimulated only p38 MAPK, but not
ERK or NF-kB. As cross-talk between MAPK and NF-kB is
highly possible, it is di⁄cult to understand the role of each path-
way in the phenotypic and functional changes in DC maturation
induced by LPS, even by using speci¢c inhibitors of each path-
way. Indeed, there is a controversy about the role of p38 MAPK
in NF-kB activation by LPS. Using SB203580, Chen and Wang
(1999) has reported that activation of p38 MAPK but not ERK
by LPS resulted in the stimulation of NF-kB-speci¢c DNA-pro-
tein binding, whereas Baldassare et al (1999) and Garrett et al
(1999) demonstrated that LPS-stimulated NF-kB activation was
not a¡ected by the activation of p38 MAPK. By using DNCB,
our studies could clearly demonstrate that p38 MAPK mediated
the augmentation of CD86 and HLA-DR, and the increased pro-
duction of IL-8 without NF-kB activation. On the other hand,
NiCl2 activated p38 MAPK, ERK, and NF-kB. The augmenta-
tion of CD83 in MoDC stimulated by NiCl2, however, was sup-
pressed by SB203580, but not by either PD98059 or PDTC,
which suggested that p38 MAPK mediates this phenomenon. It
is not clear why DNCB that also stimulates p38 MAPK cannot
augment CD83, whereas NiCl2 increases it via activation of p38
MAPK. The augmentation of CD83 may require other signals
distinct from p38 MAPK. In addition, we found that NiCl2 in-
duced the augmentation of CD86, which was not suppressed by
SB203580, PD98059, or even by PDTC. So far we have not
known how NiCl2 augments the expression of CD86.
Unexpectedly, in our experiments, PD98059 augmented the
expression of costimulatory molecules and HLA-DR antigen
without any other exogenous stimulations, and it enhanced the
expression of these molecules and the production of IL-12p40 sy-
nergistically with haptens. These data suggest that ERK may
function as a suppressive signal for DC maturation. Our culture
system that contained fetal bovine serum, IL-4, and GM-CSF
might have induced a suppressive signal that is mediated by
ERK.
Finally, in the sensitization phase of allergic contact hypersen-
sitivity, the application of haptens induces several phenotypic and
functional changes in DC that have been reported by several
authors (Staquet et al, 1992; Aiba et al, 1993; Schwarzenberger and
Udey, 1996; Kobayashi, 1997;Weiss et al, 1997; Dieu et al, 1998; Eb-
ner et al, 1998; Sallusto et al, 1998; Saeki et al, 1999). Enk and Katz
(1992) indicated the crucial role played by IL-1b secreted by Lan-
gerhans cells themselves in these phenomena. Our present data
suggest that, before IL-1b secretion by DC, haptens stimulate
MAPK or NF-kB, which subsequently stimulates the augmenta-
tion of various surface molecules and the production of cyto-
kines, such as IL-1b or TNF-a.
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